BAJAJ BROKING

Notification close image
No new Notification messages
card image
Euro Pratik Sales Ltd IPO
Apply for the Euro Pratik Sales Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

530697

ZENLABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Zenlabs Ethica Limited Share Price Update

As of the latest trading session, Zenlabs Ethica Limited share price is currently at ₹ 32.5, which is up by ₹ 0.63 from its previous closing. Today, the stock has fluctuated between ₹ 31.26 and ₹ 32.80. Over the past year, Zenlabs Ethica Limited has achieved a return of -30.65 %. In the last month alone, the return has been 2.24 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Zenlabs Ethica Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    21.30

  • P/E Ratio (TTM)

    79.65

  • Beta

    0.74

  • Book Value / share

    16.01

  • Return on equity

    2.63%

  • EPS (TTM)

    0.40

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.03

info icon alternate text

Zenlabs Ethica Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 11.48
Operating Expense 11.44
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.05
EBITDA 0.54
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 12.99
Operating Expense 12.87
Net Profit 0.09
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.14
EBITDA 0.70
Effective Tax Rate (%) 37.50
Particulars DEC 2024 (Values in Cr)
Revenue 12.72
Operating Expense 12.60
Net Profit 0.09
Net Profit Margin (%) 0.70
Earnings Per Share (EPS) 0.13
EBITDA 0.69
Effective Tax Rate (%) 30.76
Particulars SEP 2024 (Values in Cr)
Revenue 13.35
Operating Expense 13.28
Net Profit 0.05
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.08
EBITDA 0.62
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 12.36
Operating Expense 12.30
Net Profit 0.04
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.06
EBITDA 0.62
Effective Tax Rate (%) 42.85
Particulars MAR 2025 (Values in Cr)
Revenue 51.42
Operating Expense 51.05
Net Profit 0.27
Net Profit Margin (%) 0.52
Earnings Per Share (EPS) 0.41
EBITDA 2.62
Effective Tax Rate (%) 37.20
Particulars MAR 2024 (Values in Cr)
Revenue 58.56
Operating Expense 58.28
Net Profit 0.42
Net Profit Margin (%) 0.71
Earnings Per Share (EPS) 0.65
EBITDA 2.70
Effective Tax Rate (%) 27.58
Particulars MAR 2023 (Values in Cr)
Revenue 66.89
Operating Expense 65.76
Net Profit 0.49
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.75
EBITDA 2.45
Effective Tax Rate (%) 28.35
Particulars MAR 2022 (Values in Cr)
Revenue 69.09
Operating Expense 67.91
Net Profit 0.82
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.26
EBITDA 2.52
Effective Tax Rate (%) 34.92
Particulars MAR 2021 (Values in Cr)
Revenue 56.64
Operating Expense 55.83
Net Profit 0.83
Net Profit Margin (%) 1.46
Earnings Per Share (EPS) 1.41
EBITDA 1.23
Effective Tax Rate (%) 9.78
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.01
ROE % 2.63
ROCE % 5.32
Total Debt to Total Equity 1.34
EBITDA Margin 5.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.55
ROE % 4.24
ROCE % 6.51
Total Debt to Total Equity 1.04
EBITDA Margin 4.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.91
ROE % 9.46
ROCE % 11.42
Total Debt to Total Equity 0.51
EBITDA Margin 4.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.34
ROE % 8.72
ROCE % 12.25
Total Debt to Total Equity 0.36
EBITDA Margin 3.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.16
ROE % 9.64
ROCE % 11.52
Total Debt to Total Equity 0.21
EBITDA Margin 3.28
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 40.62
Total Liabilities 40.62
Total Equity 10.42
Share Outstanding 6510015
Price to Book Ratio 1.95
Return on Assets (%) 0.66
Return on Capital (%) 1.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 40.25
Total Liabilities 40.25
Total Equity 10.12
Share Outstanding 6510015
Price to Book Ratio 2.67
Return on Assets (%) 1.04
Return on Capital (%) 1.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 43.49
Total Liabilities 43.49
Total Equity 9.70
Share Outstanding 6510015
Price to Book Ratio 4.63
Return on Assets (%) 1.12
Return on Capital (%) 3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 37.89
Total Liabilities 37.89
Total Equity 9.33
Share Outstanding 6510015
Price to Book Ratio 1.99
Return on Assets (%) 2.06
Return on Capital (%) 7.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.69
Total Assets 32.20
Total Liabilities 32.20
Total Equity 8.56
Share Outstanding 6510015
Price to Book Ratio 1.61
Return on Assets (%) 2.38
Return on Capital (%) 8.58
Particulars MAR 2025 (Values in Cr)
Net Income 0.42
Cash from Operations 4.04
Cash from Investing 0.13
Cash from Financing -3.08
Net change in Cash 0.88
Free Cash Flow 4.06
Particulars MAR 2024 (Values in Cr)
Net Income 0.58
Cash from Operations -8.93
Cash from Investing 0.10
Cash from Financing 8.23
Net change in Cash -0.71
Free Cash Flow -8.90
Particulars MAR 2023 (Values in Cr)
Net Income 0.67
Cash from Operations 1.78
Cash from Investing -1.46
Cash from Financing 0.06
Net change in Cash 0.11
Free Cash Flow 3.33
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.31
Net change in Cash -0.06
Free Cash Flow -0.23
Particulars MAR 2021 (Values in Cr)
Net Income 0.86
Cash from Operations -8.31
Cash from Investing 0.15
Cash from Financing -0.52
Net change in Cash -8.78
Free Cash Flow -8.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 12.86 1.72 241.47 30.00 / 68.00
BLISS GVS PHARMA LTD. 152.50 15.10 1.53 1609.97 105.05 / 190.65
CIPLA LTD. 1573.80 23.57 4.07 127124.34 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 363.70 10.24 2.95 1070.41 219.00 / 449.00
GLAXOSMITHKLINE PHARMACEUTICAL 2774.95 49.64 24.09 47009.33 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 17.13 4.97 241.47 30.00 / 68.00
AMRUTANJAN HEALTH CARE LTD. 755.35 40.05 6.68 2183.76 548.05 / 829.00
ASTRAZENECA PHARMA INDIA LTD. 9004.20 106.45 29.22 22510.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD. 152.50 22.80 1.52 1609.97 105.05 / 190.65

Zenlabs Ethica Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
32.67 2.54 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 32.20
  • 26 Days 32.30
  • 10 Days 32.30
  • 50 Days 32.60
  • 12 Days 32.20
  • 100 Days 33.00
  • 20 Days 32.30
  • 200 Days 34.40
32.32 PIVOT

First Support

31.24

First Resistance

32.91

Second Support

30.65

Second Resistance

33.99

Third Support

29.57

Third Resistance

34.58

RSI

47.15

ADX

36.96

MACD

-0.06

Williams % R

-72.03

Commodity Channel Index (CCI)

-10.76

Date

2025-09-12

Week

1697.00

Same Day

1370.00

Month

1295.00

1 Year

0.74

3 Year

0.54

Over 1 Month

2.24%

down

Over 1 Year

-30.65%

down

Over 3 Months

-1.72%

down

Over 3 Years

-21.19%

down

Over 6 Months

5.57%

down

Over 5 Years

5.16%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Zenlabs Ethica Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
47.03%
Promoter Holdings
52.96%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Preet Remedies Limited 1730455.0 (26.58%) Shareholding of Promoter and Promoter Group
Sanjay Dhir 857728.0 (13.18%) Shareholding of Promoter and Promoter Group
Sanjeev Kumar Singal 857574.0 (13.17%) Shareholding of Promoter and Promoter Group
Hitesh Popatlal Oswal 441962.0 (6.79%) Public Shareholding
B S Mallikarjuna 139385.0 (2.14%) Public Shareholding
Bhasakarrai Kanyalal Bhatt 120945.0 (1.86%) Public Shareholding
Shyama Goyal 79454.0 (1.22%) Public Shareholding
Harjinder Kaur 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Himjyoti 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Daman Singhal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kulwant Kaur 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Zenlabs Ethica Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
29 Jul 2022 0.25 Interim 01 Aug 2022 Equity shares
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
13 Oct 2018 11 Oct 2018 1:20
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Zenlabs Ethica Limited Share Price

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network. It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019.

The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people. Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

In 2023, the Company has ventured into diversified segments like Neurology and Cytrics. It manufactures drugs for varied brands and sticks to international standards and prescribed norms. These drugs are marketed in factory packaging. As a WHO GMP certified company, the quality of each product is of highly advanced procurement & supply facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zenlabs Ethica Ltd?

Answer Field

Zenlabs Ethica Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 32.67 as on Sep 16 2025 12:51 PM.

What is the Market Cap of Zenlabs Ethica Ltd Share?

Answer Field

The market cap of Zenlabs Ethica Ltd for NSE ₹ 0.00 & for BSE ₹ 21.30 as on Sep 16 2025 12:51 PM.

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

Answer Field

The 52 Week High and Low of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 50.50 and ₹ 27.33.

What is 1 year return for Zenlabs Ethica Ltd?

Answer Field

The 1 year returns on the stock has been -33.50%.

What is the P/E Ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Sep 16 2025 12:51 PM the price-to-earnings (PE) ratio for Zenlabs Ethica Ltd share is 79.65.

What is the PB ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Sep 16 2025 12:51 PM, the price-to-book (PB) ratio for Zenlabs Ethica Ltd share is 16.01.

How to Buy Zenlabs Ethica Ltd Share?

Answer Field

You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenlabs Ethica Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenlabs Ethica Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenlabs Ethica Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91